133 related articles for article (PubMed ID: 16815537)
1. Potential underdosing of carboplatin in gynecological malignancies.
de Lemos ML; Hamata L; Conklin J; Swenerton K
Gynecol Oncol; 2006 Sep; 102(3):599. PubMed ID: 16815537
[No Abstract] [Full Text] [Related]
2. The unexpected burden of hypomagnesaemia in gynae-oncology chemotherapy clinics.
Herbert C; Cornes P
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):373-4. PubMed ID: 21296563
[No Abstract] [Full Text] [Related]
3. Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
Schwartz JR; Bandera C; Bradley A; Brard L; Legare R; Granai CO; Dizon DS
Gynecol Oncol; 2007 Apr; 105(1):81-3. PubMed ID: 17157366
[TBL] [Abstract][Full Text] [Related]
4. [Reasonable applications of chemotherapy in gynecological malignancy].
Shen K
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):73-4. PubMed ID: 16640850
[No Abstract] [Full Text] [Related]
5. The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer management.
Markman M
Gynecol Oncol; 2007 Nov; 107(2):163-5. PubMed ID: 17675141
[No Abstract] [Full Text] [Related]
6. [Key problems of chemotherapy for gynecological malignancies].
Tan XJ; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):561-3. PubMed ID: 23141172
[No Abstract] [Full Text] [Related]
7. [Synopsis of the third national seminar on chemotherapy for gynecological malignancies].
Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):564-5. PubMed ID: 23141173
[No Abstract] [Full Text] [Related]
8. [Chemotherapy of advanced gynecological cancer and its limitation--findings in compound and multidisciplinary treatment].
Katashima S; Iwasaki M
Nihon Gan Chiryo Gakkai Shi; 1983 Apr; 18(3):704-15. PubMed ID: 6619636
[No Abstract] [Full Text] [Related]
9. Current dilemmas in carboplatin dosing.
Ratain MJ
Clin Adv Hematol Oncol; 2011 Mar; 9(3):237-8. PubMed ID: 21475131
[No Abstract] [Full Text] [Related]
10. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
du Bois A; Pfisterer J; Burchardi N; Loibl S; Huober J; Wimberger P; Burges A; Stähle A; Jackisch C; Kölbl H; ;
Gynecol Oncol; 2007 Dec; 107(3):518-25. PubMed ID: 17910981
[TBL] [Abstract][Full Text] [Related]
11. [Observations of treatment with endolymphatic administration of cytostatic agents in some cases of gynecological neoplasms].
Cugniolio G; Gualerzi C; Beghetti U; Panciroli G
Minerva Chir; 1966 Apr; 21(7):276-80. PubMed ID: 5939741
[No Abstract] [Full Text] [Related]
12. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?
Memtsas V; Zarros A; Theocharis S
Expert Opin Ther Targets; 2009 Sep; 13(9):1105-20. PubMed ID: 19604124
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of malignant gynecological tumor--arterial infusion and biological response modifiers(BRM)].
Fujiwara S; Akiya K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):2025-30. PubMed ID: 6663134
[No Abstract] [Full Text] [Related]
14. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.
Chitapanarux I; Lorvidhaya V; Kamnerdsupaphon P; Sumitsawan Y; Tharavichitkul E; Sukthomya V; Ford J
Eur J Cancer; 2007 Jun; 43(9):1399-406. PubMed ID: 17467265
[TBL] [Abstract][Full Text] [Related]
15. [Current trends in obstetrical-gynecological antiblastic chemotherapy].
Variati G
Ann Ostet Ginecol Med Perinat; 1966 Oct; 88(10):797-806. PubMed ID: 6011759
[No Abstract] [Full Text] [Related]
16. [The role of chemotherapy in the treatment of gynecological tumours (author's transl)].
Trnka V
Cesk Gynekol; 1976 Dec; 41(10):713-6. PubMed ID: 1009600
[No Abstract] [Full Text] [Related]
17. [Nursing of gynecological patients treated by chemotherapy].
Xian M
Zhonghua Hu Li Za Zhi; 1985 Jun; 20(3):156-8. PubMed ID: 3849358
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of repeated monthly carboplatin desensitization.
Morgan M; Bowers DC; Gruchalla RS; Khan DA
J Allergy Clin Immunol; 2004 Oct; 114(4):974-5. PubMed ID: 15480344
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of calculating carboplatin dosage using Japanese equation for estimating GFR for gynecologic cancer].
Kidera Y; Nakao M; Tsubaki M; Yoshinaga M; Kajitani F; Yanae M; Sakano M; Yamazoe Y; Chiba Y; Moriyama K; Nishida S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1143-8. PubMed ID: 21772099
[TBL] [Abstract][Full Text] [Related]
20. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
